Biomarkers for the early diagnosis of hepatocellular carcinoma / 临床肝胆病杂志
Journal of Clinical Hepatology
;
(12): 176-179, 2021.
Article
in Chinese
| WPRIM
| ID: wpr-862564
ABSTRACT
Patients with advanced hepatocellular carcinoma (HCC) often have poor prognosis, and early diagnosis and effective treatment measures can significantly improve the survival rate of patients. At present, alpha-fetoprotein (AFP) is the most widely used serum marker for the diagnosis of HCC in the world; however, no increase in AFP was found in some HCC patients. This article analyzes the application potential of AFP, hepatitis B core-related antigen, liquid biopsy technology, microRNA, long non-coding RNA, and exosomes in the early diagnosis of HCC and reviews related research advances, so as to provide a basis for exploring new methods for the early diagnosis of HCC.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Diagnostic study
/
Screening study
Language:
Chinese
Journal:
Journal of Clinical Hepatology
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS